MARKET

NRXPW

NRXPW

Nrx Pharmaceuticals Inc
NASDAQ
0.0870
+0.0001
+0.12%
Closed 12:46 12/05 EST
OPEN
0.0769
PREV CLOSE
0.0869
HIGH
0.0870
LOW
0.0762
VOLUME
9.89K
TURNOVER
--
52 WEEK HIGH
0.5000
52 WEEK LOW
0.0500
MARKET CAP
--
P/E (TTM)
-0.0375
1D
5D
1M
3M
1Y
5Y
1D
NRX PHARMACEUTICALS INC - AMENDS IND FILING FOR NRX-101 TO INCLUDE TMS USE
Reuters · 3d ago
NRX PHARMACEUTICALS INC - APPLIES FOR KETAFREE AS PROPRIETARY PRODUCT NAME
Reuters · 4d ago
FDA Accepts NRx Pharmaceuticals' ANDA for KETAFREE with Review Goal Date Set
Reuters · 4d ago
NRX Pharmaceuticals to Present at NobleCon21 Emerging Growth Equity Conference
Reuters · 5d ago
Weekly Report: what happened at NRXPW last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at NRXPW last week (1117-1121)?
Weekly Report · 11/24 09:30
NRx Pharmaceuticals outlines rapid clinic expansion and targets 6 or more locations by year-end 2025 amid new depression treatment advances
Seeking Alpha · 11/17 16:58
NRX Pharmaceuticals posts Q3 loss and reports first revenue after Dura Medical acquisition
Reuters · 11/17 13:05
More
About NRXPW
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic. The Company is also engaged in the development of its new product, NRX-102.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXPW stock methods without spending real money on the virtual paper trading platform.